The Curative Potential of Chimeric Antigen Receptor T-Cell Therapy for B-Cell Malignancies

Text Registration

The Curative Potential of Chimeric Antigen Receptor T-Cell Therapy for B-Cell Malignancies

Status

Published

on 31 Aug 2017

Year of Creation

2017

Megha Pallavi Koduri

Registration Number

TX0008491165

on 31 Aug 2017

The U.S. Copyright record (Registration Number: TX0008491165) dated 31 Aug 2017, pertains to an electronic file (eService) titled "The Curative Potential of Chimeric Antigen Receptor T-Cell Therapy for B-Cell Malignancies" created in 2017. The copyright holder is Megha Pallavi Koduri, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Megha Pallavi Koduri.

Megha Pallavi Koduri

Application Details

Registration Number

TX0008491165

Registration Date

8/31/2017

Year of Creation

2017

Agency Marc Code

DLC-CO

Record Status

New

Physical Description

Electronic file (eService)

First Publication Nation

United States

Personal Authors

Megha Pallavi Koduri

Notes

Rights Note: Mark Dill, ProQuest-CSA, LLC, 789 E. Eisenhower Parkway, Ann Arbor, MI, 48108-3218, United States, (800) 521-0600, disspub@proquest.com

Statements

Application Title Statement: The Curative Potential of Chimeric Antigen Receptor T-Cell Therapy for B-Cell Malignancies

Author Statement: Megha Pallavi Koduri Citizenship: United States Authorship: text

Notes

Rights Note: Mark Dill, ProQuest-CSA, LLC, 789 E. Eisenhower Parkway, Ann Arbor, MI, 48108-3218, United States, (800) 521-0600, disspub@proquest.com

Statements

Application Title Statement: The Curative Potential of Chimeric Antigen Receptor T-Cell Therapy for B-Cell Malignancies

Author Statement: Megha Pallavi Koduri Citizenship: United States Authorship: text

Get your copyright registered todayThousands have copyrighted their assets.
What are you waiting for?

Show terms & conditions

Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.